Recent Updates — NORD
On October 15, 2026, Nordicus Partners Corporation issued a promissory note to ABCHill Holding ApS for $147,000. The lender is wholly owned by Christian Hill-Madsen, who serves as CEO of subsidiary NP Bioinnovation A/S and COO of NoviThera ApS, and is also a director of subsidiaries Orocidin A/S and Bio-Convert A/S. The note bears interest at the lesser of 6.0% per annum or the maximum legal rate, is payable on demand, and may be prepaid without penalty. This transaction represents a related-party loan filed under Item 1.01 and Item 2.03.
Nordicus Partners Corporation operates as a holding company focused on investments in biotechnology and life sciences companies.
On October 8, 2026, Nordicus Partners Corporation issued a promissory note to AC Nordic ApS for $75,000. The lender is wholly owned by Torben Jensen, a board member, making this a related-party transaction approved by disinterested directors. The note bears interest at the lesser of 6.0% per annum or the legal maximum, payable on demand. Proceeds are for working capital and general corporate purposes. Nordicus Partners Corporation operates in the investment management industry.
On September 10, 2026, Nordicus Partners Corporation entered into a definitive agreement with Keystone Capital Partners LLC to issue a Convertible Grid Promissory Note with a principal amount of $600,000. The company received $500,000 in cash proceeds and issued 250,000 commitment shares as consideration for the funding commitment. The note bears interest at 5.0% per annum and matures on June 10, 2027, with a prepayment premium of 120%. Conversion rights are restricted to events of default occurring after maturity, calculated at 90% of the ten-day volume-weighted average price. The company is obligated to file a registration statement for the convertible securities by November 1, 2026. Nordicus Partners Corporation operates in the financial services industry, acting as an investment vehicle.
On September 1, 2026, Nordicus Partners Corporation appointed Elizabeth Addonizio to its Board of Directors to fill the vacancy created by Andrew Ritter's resignation. Addonizio brings 25 years of experience in venture and private equity investing, including prior roles as a managing director at Cranemere and an advisor at Morgan Stanley on over $25 billion in transactions. Her compensation includes an annual cash retainer of $10,000 and fully vested options to purchase 25,000 shares at $4.09 per share under the Company’s 2024 Stock Incentive Plan. Nordicus Partners Corporation operates as a special purpose acquisition company (SPAC) focused on identifying and merging with private companies.
Andrew J. Ritter resigned from the Board of Directors and all committee memberships of Nordicus Partners Corporation, effective July 7, 2026. The resignation was not due to any disagreement with the company's operations, policies, or practices. Nordicus Partners Corporation is a Delaware-incorporated corporation operating in the financial services sector.